The autoregulated bioprosthetic total artificial heart in advanced biventricular failure: 180-day outcomes from the EFICAS study

31 August 2026 (11:45 - 12:00)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Professor Andre Vincentelli

Chru De Lille - Institut Coeur-Poumons, Lille (France)

3 More presentations in this session

Presentation thumbnail

Outcomes of Intracoronary AAV1/SERCA2a Gene Therapy in Patients With Heart Failure With Preserved Ejection Fraction: 12-Month Results From the MUSIC-HFpEF Phase 1/2a Trial

Doctor M. Fudim (Durham, US)

Presentation thumbnail

CIRRUS-HCM: 12-Week Evaluation of the Safety and Efficacy of the Novel Cardiac Sarcomere Modulator EDG-7500 in Nonobstructive and Obstructive Hypertrophic Cardiomyopathy

Doctor A. Owens (Philadelphia, US)

Presentation thumbnail

Intravenous Dexrazoxane for Hemorrhagic Myocardial Infarction in STEMI: A Double-Blind, Placebo-Controlled, Sequential-Cohort Phase IIa Trial (SHIELD-MI)

Doctor K. Vora (Indianapolis, US)

Access the full session

Session thumbnail

Transforming the heart: novel therapies for myocardial disease and heart failure

The Event

Event poster

ESC Congress 2026

31 August 2026 11:45 CET

You may be interested in

Congress Session

Showcasing successes in advanced heart failure

30 August 2024

Congress Presentation

Biological left ventricular assist device: engineering a cure for the failing heart

30 August 2026

Congress Presentation

When all is lost, can we put in a total artificial heart?

19 March 2022

Congress Presentation

The TRICURE FIH study results and future trials update

31 August 2026

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources